// App-Quantinova.ai

: MYSEC-PROGNOSTIC MODEL AND PREVIOUS THROMBOTIC EVENTS PREDICT THE RISK OF THROMBOSIS IN POST POLYCYTHEMIA VERA AND POST ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: A STUDY OF THE MYSEC GROUP

Researchers

Presenter

  • Barbara Mora

Principal Investigators

  • Paola Guglielmelli

  • Elisa Rumi

  • Margherita Maffioli

  • Rami Komrokji

  • Daniela Barraco

  • Alessandro Rambaldi

  • Marianna Caramella

  • Jean Jacques Kiladjian

  • Jason Gotlib

  • Alessandra Iurlo

  • Francisco Cervantes

  • Timothy Devos

  • Francesca Palandri

  • Valerio De Stefano

  • Marco Ruggeri

  • Richard T. Silver

  • Giulia Benevolo

  • Francesco Albano

  • Chiara Cavalloni

  • Daniela Pietra

  • Daniele Cattaneo

  • Michele Merli

  • Tiziano Barbui

  • Giada Rotunno

  • Lorenza Bert

  • Mario Cazzola

  • Alessandro Maria Vannucchi

  • Francesco Passamonti

Medical Centers

  • Hematology Unit,Ospedale di Circolo ASST Sette Laghi,Varese,Italien

  • CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproliferative, Department of Experimental and Clinical Medicine, Azienda Ospedaliera-Universitaria Careggi, University of Florence, Florence, Italy

  • Otolaryngology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

  • Hematology and BMT Unit,ASST Papa Giovanni XXIII, University of Milan,Bergamo, Italy,Italy

  • Hematology,Ospedale Niguarda Ca' Granda,Milan,Italy

  • Hematology,Hôpital Saint-Louis et Université Paris Diderot,Paris,France

  • Medicine, Stanford University, Stanford, CA, United States

  • Oncohematology Division, IRCCS Ca Granda Maggiore Policlinico Hospital Foundation, Milan, Italy

  • Hospital Clínic, IDIBAPS, University of Barcelona,Barcelona,España

  • Hematology,University Hospitals Leuven and Laboratory of Experimental Transplantation, Department of Microbiology and Immunology,KU Leuven,Belgium

  • Hematology,Policlinico S. Orsola-Malpighi,Bologna, Italy,Italy

  • Hematology, Universita Cattolica S. Cuore, Rome, Italy

  • Hematology, Ospedale S. Bortolo, Vicenza, Italy

  • Oncology,Weill Cornell Medical Center,New York,United States

  • Hematology,Centro Oncologico Ematologico Subalpino (COES),Torino,Italy

  • Hematology, University of Bari, Bari, ITA

  • FROM Research Foundation,ASST Papa Giovanni XXIII,Bergamo, Italy,Italy

  • Department of Medicine and Surgery, University of Insubria, Varese, Italy

  • Hematology,Ospedale di Circolo, ASST Sette Laghi,Varese,Italy;Medicine and Surgery,University of Insubria,Varese,Italy

Locations

  • Italy

  • United States

  • France

  • Spain

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Essential thrombocythemia

  • Polycythemia vera

  • Myelofibrosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved